CD8A and relapsing-remitting multiple sclerosis: Administration of rapamycin to experimental allergic encephalomyelitis (EAE) Dark Agouti rats, a model of relapsing-remitting multiple sclerosis (RRMS), improved the clinical course of the disease, increasing the percentage of Tregs and reducing the number of CD8+ T cells.